538 related articles for article (PubMed ID: 30293912)
1. [Clinical and pathological profile of the pleural malignant mesothelioma: A retrospective study about 30 cases].
Mlika M; Lamzirbi O; Limam M; Mejri N; Ben Saad S; Chaouch N; Ben Miled K; Marghli A; Mezni F
Rev Pneumol Clin; 2018 Dec; 74(6):427-435. PubMed ID: 30293912
[TBL] [Abstract][Full Text] [Related]
2. How to assess the best immunohistochemical panel in the diagnosis of malignant pleural mesothelioma in a pathology lab.
Mlika M; Lamzibri O; Bacha S; Laabidi S; Haddouchi C; Mezni FE
J Immunoassay Immunochem; 2018; 39(3):263-273. PubMed ID: 29757709
[TBL] [Abstract][Full Text] [Related]
3. Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009.
Jennings CJ; Walsh PM; Deady S; Harvey BJ; Thomas W
Cancer Epidemiol; 2014 Feb; 38(1):35-41. PubMed ID: 24394956
[TBL] [Abstract][Full Text] [Related]
4. Multidetector CT Findings and Differential Diagnoses of Malignant Pleural Mesothelioma and Metastatic Pleural Diseases in Korea.
Kim YK; Kim JS; Lee KW; Yi CA; Goo JM; Jung SH
Korean J Radiol; 2016; 17(4):545-53. PubMed ID: 27390546
[TBL] [Abstract][Full Text] [Related]
5. On the diagnosis of malignant pleural mesothelioma: A necropsy-based study of 171 cases (1997-2016).
Barbieri PG; Mirabelli D; Magnani C; Brollo A
Tumori; 2019 Aug; 105(4):304-311. PubMed ID: 29714657
[TBL] [Abstract][Full Text] [Related]
6. Upcoming epidemic of asbestos-related malignant pleural mesothelioma in Taiwan: A prediction of incidence in the next 30 years.
Lin RT; Chang YY; Wang JD; Lee LJ
J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):463-470. PubMed ID: 30072200
[TBL] [Abstract][Full Text] [Related]
7. Malignant Pleural Mesothelioma: Accuracy of CT Against Immunohistochemical Test Among the Mexican Population.
Gopar-Nieto R; Aguilar-Madrid G; Sotelo-Martínez L; Juárez-Pérez CA; Kelly-García J; Argote-Greene L; Ochoa-Vázquez MD; García-Bazán EM; Ramírez-Pérez J; Haro-García L; Jiménez-Ramírez C; Cabello-López A
Arch Med Res; 2015 Feb; 46(2):107-11. PubMed ID: 25707292
[TBL] [Abstract][Full Text] [Related]
8. Malignant pleural mesothelioma: diagnostic value of medical thoracoscopy and long-term prognostic analysis.
Xu LL; Yang Y; Wang Z; Wang XJ; Tong ZH; Shi HZ
BMC Pulm Med; 2018 Apr; 18(1):56. PubMed ID: 29615010
[TBL] [Abstract][Full Text] [Related]
9. Clinical feature of diagnostic challenging cases for pleural biopsy in patient with malignant pleural mesothelioma.
Hashimoto M; Sato A; Kuroda A; Nakamura A; Nakamichi T; Kondo N; Yuki M; Nabeshima K; Tsujimura T; Hasegawa S
Gen Thorac Cardiovasc Surg; 2020 Aug; 68(8):820-827. PubMed ID: 31981139
[TBL] [Abstract][Full Text] [Related]
10. Diffuse malignant pleural mesothelioma in an urban hospital: clinical spectrum and trend in incidence over time.
Shepherd KE; Oliver LC; Kazemi H
Am J Ind Med; 1989; 16(4):373-83. PubMed ID: 2610210
[TBL] [Abstract][Full Text] [Related]
11. BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.
McGregor SM; Dunning R; Hyjek E; Vigneswaran W; Husain AN; Krausz T
Hum Pathol; 2015 Nov; 46(11):1670-8. PubMed ID: 26376834
[TBL] [Abstract][Full Text] [Related]
12. [Regional treatment of malignant pleural mesothelioma: results from the tumor centre Regensburg].
Ried M; Speth U; Potzger T; Neu R; Diez C; Klinkhammer-Schalke M; Hofmann HS
Chirurg; 2013 Nov; 84(11):987-93. PubMed ID: 23743993
[TBL] [Abstract][Full Text] [Related]
13. Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center.
Otoshi T; Kataoka Y; Ikegaki S; Saito E; Matsumoto H; Kaku S; Shimada M; Hirabayashi M
PLoS One; 2017; 12(10):e0185850. PubMed ID: 28968445
[TBL] [Abstract][Full Text] [Related]
14. [Malignant pleural mesothelioma].
Sritharan SS; Frandsen JL; Omland Ø; Bruun JM
Ugeskr Laeger; 2018 Apr; 180(15):. PubMed ID: 29690982
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological characteristics and prognosis of malignant pleural mesothelioma].
Chen WH; Zhang XL; Dai HP; Tong ZH; Zhang YH; Jin ML
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):825-8. PubMed ID: 24507393
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of Computed Tomography Imaging Features in Malignant Pleural Mesothelioma.
Fortin M; Cabon E; Berbis J; Laroumagne S; Guinde J; Elharrar X; Dutau H; Astoul P
Respiration; 2020; 99(1):28-34. PubMed ID: 31655816
[TBL] [Abstract][Full Text] [Related]
17. Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-2009.
Soeberg MJ; Leigh J; Driscoll T; Armstrong B; Young JM; van Zandwijk N
Occup Environ Med; 2016 Mar; 73(3):187-94. PubMed ID: 26800709
[TBL] [Abstract][Full Text] [Related]
18. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
[TBL] [Abstract][Full Text] [Related]
19. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales.
Beckett P; Edwards J; Fennell D; Hubbard R; Woolhouse I; Peake MD
Lung Cancer; 2015 Jun; 88(3):344-8. PubMed ID: 25863904
[TBL] [Abstract][Full Text] [Related]
20. The role of endobronchial ultrasound-guided fine needle aspiration in the diagnosis of pleural mesothelioma.
Ghigna MR; Crutu A; Florea V; Soummer-Feulliet S; Baldeyrou P
Cytopathology; 2016 Aug; 27(4):284-8. PubMed ID: 26315262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]